Results 151 to 160 of about 13,081 (222)

Grouping of chemicals for safety assessment: the importance of toxicokinetic properties of salicylate esters. [PDF]

Arch Toxicol
Najjar A, Grégoire S, Nicol B, Natsch A, Golbamaki N, Boisleve F, Irizar A, Wall B, Swinscoe A, Masini-Etévé V, Joshi K, Api AM, Griem P, Reis A, Hewitt NJ, Cardamone E.   +15 more
europepmc   +1 more source

Two Doses to ICU or When Lactate Equals Glucose: Life-Threatening Lactic Acidosis due to Metformin After Initiation of Semaglutide. [PDF]

Case Rep Crit Care
Albany Z, Roe D, Gutteridge D, Webb H, Kara A.   +4 more
europepmc   +1 more source

A Descriptive Analysis of Potential Warfarin-NSAID Interactions in Dental Prescribing in Minas Gerais, Brazil, 2011-2021. [PDF]

Healthcare (Basel)
Reis-Oliveira J, Cruz AJSD, Garcez WEPB, Santos JS, Martins MAP, Abreu MHNG.   +5 more
europepmc   +1 more source

Patterns and determinants of drug-drug interactions among community-dwelling older adults in Saudi Arabia: a cross-sectional study. [PDF]

Front Pharmacol
Khawagi WY, Aldali JA, Aljohani RM, Alshehri AA.   +3 more
europepmc   +1 more source

Grade 4 Mucositis Secondary to Methotrexate Use in a Pediatric Patient With Stage IV Burkitt Lymphoma: A Case Report. [PDF]

Cureus
Abdala Mendoza FY, Ancona Castro C.
europepmc   +1 more source

Investigating a role for NSAIDs in the pathophysiology of vaccine-associated myocarditis. [PDF]

NPJ Vaccines
Hoption Cann SA.
europepmc   +1 more source

AMPK: an enzyme that may be effective in cancer and metabolic diseases. [PDF]

Discov Oncol
Güney Kalkan S, Ceylan Ünlüsoy M.
europepmc   +1 more source

Quality of life analysis in community pharmacy using deep learning and explainability methods. [PDF]

JAMIA Open
Reyes-Medina MJ, Carrera-González MDP, Cantón-Habas V, Ávila-Jiménez JL.   +3 more
europepmc   +1 more source

Real life data with a six months follow-up from dietary interventions, biologic therapy and functional endoscopic surgery (FESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). [PDF]

Medicine (Baltimore)
Stihl C, Dombrowski T, Weiss BG, Spiegel JL, Guertler A, Ihler F, Freytag S, Bertlich I, Gröger M, Oppel E, Bertlich M.   +10 more
europepmc   +1 more source

Vedolizumab as a Second Line Biologic for Cronkhite Canada Syndrome and an Approach Toward Disease Monitoring. [PDF]

ACG Case Rep J
Pham JT, Feagins LA.
europepmc   +1 more source